1 / 3

Arteriotomy Closure Devices: Market Characterization

Arteriotomy closure devices are used for carrying out hemostasis after the completion of a Percutaneous Intervention (PCI).

rgunnam
Download Presentation

Arteriotomy Closure Devices: Market Characterization

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Arteriotomy Closure Devices: Market Characterization

  2. Arteriotomy closure devices are used for carrying out hemostasis after the completion of a Percutaneous Intervention (PCI). It is used as an alternative to manual or mechanical compression. Manual or mechanical compression is applied for 15-30 minutes, and is typically combined with an extended bed-rest of three to six hours. However, manual compression techniques often cause patient discomfort, especially for the elderly and for patients with pre-existing back and hip pain. In addition to the associated patient discomfort, compression techniques are time and resource intensive. Arteriotomy closure devices on the other hand shorten procedure times, allow patients to ambulate earlier, minimize bleeding and reduce costs. The first arteriotomy closure device, Femostop was introduced in 1992 by RADI Medical Systems AB. The device enabled accurate application of mechanical pressure over the arteriotomy. The global arteriotomy closure device market was valued at $568.9m in 2009 having grown at a CAGR of 5% from 2002. The launch of new and safer products such as StarClose by Abbott Vascular Devices and EVS-Angiolink by Medtronic during this period has led to significantly greater adoption by interventional cardiologists. This analysis was taken from a research paper published by GlobalData, to download the full Research Paper for free, click below: http://www.researchviews.com/healthcare/medical/cardiovasculardevices/Viewpoints.aspx?sector=Cardiovascular%20Devices&DocID=10538 Access the latest Cardiovascular Devices analysis for free at http://www.researchviews.com

  3. About ResearchViews.com ResearchViews is your number one portal for industry related news, research, analysis and deals data. ResearchViews offers up to the minute content produced by an expert team of industry analysts. All content on the site is free to view and allows users to keep up to date with the latest developments in their chosen industry. Free daily and weekly newsletters provide a snapshot of the major issues affecting the industry. The site also features a research store, providing the user with access to premium business intelligence from some of the world's leading market research publishers. Contact Information: Rajesh Gunnam rgunnam@globaldata.com +914066166782

More Related